Table 5. Variable analysis in the PECS group according to the types of anesthetic (subgroups).
| Variable | lLevobupivacaine | Ropivacaine | p-value |
|---|---|---|---|
| n (%) | n (%) | ||
| Histological Type | |||
| IDC | 15 (93.75) | 22 (91.67) | 0.417 |
| Carcinoma in situ | 0 (0.00) | 1 (4.17) | |
| Lobular carcinoma | 1(6.25) | 0 (0.00) | |
| Staging | |||
| T1 | 0 (0.00) | 3 (12.50) | 0.327 |
| T2 | 6 (40.00) | 5 (20.83) | |
| T3 | 4 (26.67) | 9 (37.50) | |
| T4 | 5 (33.33) | 7 (29.17) | |
| Molecular classification of the tumor | |||
| Luminal A | 7 (43.75) | 9 (56.25) | 0.035 |
| Luminal B | 4 (25.00) | 9 (37.50) | |
| Triple negative | 0 (0.00) | 5 (20.83) | |
| Undetermined | 5 (31.25) | 1 (4.17) | |
| VAS pain scale | |||
| No pain | 7 (43.75) | 13 (54.17) | 0.335 |
| Mild pain | 8 (50.00) | 9 (37.50) | |
| Moderate pain | 0 (0.00) | 2 (8.33) | |
| Severe pain | 1 (6.25) | 0 (0.00) |
The data are presented as the mean (SD) and proportion (%) in each subgroup represented by anesthesia in PECS block with levobupivacaine and ropivacaine. *Chi-square test.